Artemis Medicare Services cash flow

Latest FY26

Cash from operations: ₹132cr−9.4% on FY25
Capital spending: ₹105cr+12.7% on FY25
Free cash flow: ₹27.0cr−48.5% on FY25
Cash from financing: −₹50.1cr₹267 cr in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Changes in working capital
Adjustments to reconcile profit — non-cash items						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	—	48.1	45.2	40.3	31.0
	—	27.7	28.5	27.8	17.2
	—	−24.3	−26.6	−4.3	−3.0
	—	0.0	0.9	2.2	4.0
	—	0.1	0.1	0.0	−0.2
	—	2.4	3.0	2.1	2.1
	—	−4.1	−2.6	−8.0	−2.0
	—	−3.4	0.1	3.9	−1.6
	—	−20.7	−9.7	−3.7	−21.8
	—	0.4	−3.5	0.5	−1.0
	—	0.0	−1.0	−0.1	−0.9
	—	−9.3	−4.3	−0.4	2.5
	—	0.0	0.3	−11.1	−8.8
	—	−1.4	7.1	7.5	29.1
	—	−14.4	6.8	−11.2	0.0
	—	2.0	4.4	−1.2	5.8
	—	0.0	0.0	0.0	24.9
	—	6.4	1.5	1.3	0.7
	—	0.0	1.5	0.6	1.3
Cash from operating activities
	154	139	108	68.5	50.6
	—	9.3	51.8	46.2	79.4
	—	149	159	115	130
	—	16.6	13.8	5.8	2.9
	—	132	146	109	127
Cash from investing activities
	—	105	93.2	72.6	146
	—	4.9	2.6	0.3	1.5
	—	3.6	0.0	0.0	0.0
	—	28.7	12.5	3.9	2.8
	—	−15.2	−307	−18.7	−16.1
	—	−90.0	−385	−87.0	−158
Cash from financing activities
	—	0.2	0.2	2.0	3.5
	—	0.0	330	0.0	0.0
	—	64.2	20.8	45.3	82.8
	—	77.8	35.9	33.3	24.8
	—	6.7	9.7	9.1	5.6
	—	23.5	23.6	27.8	17.2
	—	6.1	6.0	6.1	0.0
	—	−0.3	−9.1	−1.1	−0.4
	—	−50.1	267	−30.1	38.2
	—	−8.2	27.0	−8.3	7.2
	—	−8.2	27.0	−8.3	7.2
	—	—	—	14.6	22.9
Reference items
	207	188	152	133	93.9
	18.0%	17.4%	16.2%	15.1%	12.7%
	27.0	27.0	52.5	36.3	−19.3
	—	−15.5	21.1	20.6	—
	₹1.71	₹1.71	₹3.31	₹2.29	−₹1.22
	174.69×	—	—	—	—
	—	1.27×	1.77×	2.21×	3.35×
	—	16.6	13.8	5.8	2.9
	—	23.5	23.6	27.8	17.2

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ARTEMISMED₹297.95

Artemis Medicare Services Limited

· Pharma & Health

₹ CrorePeersINDRAMEDCO SHALBY GKSL GPTHEALTH LOTUSEYE DRAGARWQ KMCSHIL KOVAIMcap ₹4,717 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	31.0	40.3	45.2	48.1	—
+ Finance Costs	17.2	27.8	28.5	27.7	—
+ Interest Income	-3.0	-4.3	-26.6	-24.3	—
+ Share-based Payments	4.0	2.2	0.9	0.0	—
+ Unrealised FX (Gain) / Loss	-0.2	0.0	0.1	0.1	—
+ Other Non-cash Items	2.1	2.1	3.0	2.4	—
+ Other Reconciling Items	-2.0	-8.0	-2.6	-4.1	—
Changes in Working Capital
+ Inventories	-1.6	3.9	0.1	-3.4	—
+ Trade Receivables — Current	-21.8	-3.7	-9.7	-20.7	—
+ Other Financial Assets — Current	-1.0	0.5	-3.5	0.4	—
+ Other Financial Assets — Non-current	-0.9	-0.1	-1.0	0.0	—
+ Other Current Assets	2.5	-0.4	-4.3	-9.3	—
+ Other Non-current Assets	-8.8	-11.1	0.3	0.0	—
+ Trade Payables — Current	29.1	7.5	7.1	-1.4	—
+ Other Financial Liabilities — Current	0.0	-11.2	6.8	-14.4	—
+ Other Current Liabilities	5.8	-1.2	4.4	2.0	—
+ Other Non-current Liabilities	24.9	0.0	0.0	0.0	—
+ Provisions — Current	0.7	1.3	1.5	6.4	—
+ Provisions — Non-current	1.3	0.6	1.5	0.0	—
Cash from Operating Activities
Profit Before Tax (per I/S)	50.6	68.5	107.7	139.2	153.6
+ Total Adjustments (incl. Working Capital)	79.4	46.2	51.8	9.3	—
Cash from Operations (pre-tax)	130.0	114.7	159.5	148.5	—
+ Income Taxes Paid	2.9	5.8	13.8	16.6	—
Cash from Operating Activities	127.2	108.9	145.6	131.9	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	146.5	72.6	93.2	104.9	—
+ Disp of Fixed Assets	1.5	0.3	2.6	4.9	—
+ Loans & Advances Made	0.0	0.0	0.0	3.6	—
+ Interest Received — Investing	2.8	3.9	12.5	28.7	—
+ Other Inflows / (Outflows) — Investing	-16.1	-18.7	-307.3	-15.2	—
Cash from Investing Activities	-158.2	-87.0	-385.4	-90.0	—
Cash from Financing Activities
+ Proceeds from Issue of Shares	3.5	2.0	0.2	0.2	—
+ Proceeds from Debentures / Notes / Bonds	0.0	0.0	330.0	0.0	—
+ Proceeds from Borrowings	82.8	45.3	20.8	64.2	—
+ Repayment of Borrowings	24.8	33.3	35.9	77.8	—
+ Payment of Lease Liabilities	5.6	9.1	9.7	6.7	—
+ Interest Paid	17.2	27.8	23.6	23.5	—
+ Dividends Paid	0.0	6.1	6.0	6.1	—
+ Other Inflows / (Outflows) — Financing	-0.4	-1.1	-9.1	-0.3	—
Cash from Financing Activities	38.2	-30.1	266.7	-50.1	—
Net Changes in Cash (pre-FX)	7.2	-8.3	27.0	-8.2	—
Net Changes in Cash	7.2	-8.3	27.0	-8.2	—
Closing Cash	22.9	14.6	—	—	—
Reference Items
EBITDA	93.9	132.7	151.8	188.2	207.4
EBITDA Margin %	12.74	15.10	16.20	17.40	18.04
Free Cash Flow (CFO − Capex)	-19.3	36.3	52.5	27.0	27.0
Free Cash Flow to Equity	—	20.6	21.1	-15.5	—
Free Cash Flow per Basic Share	-1.22	2.29	3.31	1.71	1.71
Price to Free Cash Flow	—	—	—	—	174.69
Cash Flow to Net Income	3.35	2.21	1.77	1.27	—
Cash Paid for Taxes	2.9	5.8	13.8	16.6	—
Cash Paid for Interest	17.2	27.8	23.6	23.5	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.